Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA
J Pharmacol Exp Ther. 2021 May;377(2):232-241. doi: 10.1124/jpet.120.000464. Epub 2021 Feb 23.
This study evaluated a battery of pain-stimulated, pain-depressed, and pain-independent behaviors for preclinical pharmacological assessment of candidate analgesics in mice. Intraperitoneal injection of dilute lactic acid (IP acid) served as an acute visceral noxious stimulus to produce four pain-related behaviors in male and female ICR mice: stimulation of 1) stretching, 2) facial grimace, 3) depression of rearing, and 4) depression of nesting. Additionally, nesting and locomotion in the absence of the noxious stimulus were used to assess pain-independent drug effects. These six behaviors were used to compare effects of two mechanistically distinct but clinically effective positive controls (ketoprofen and oxycodone) and two negative controls that are not clinically approved as analgesics but produce either general motor depression (diazepam) or motor stimulation (amphetamine). We predicted that analgesics would alleviate all IP acid effects at doses that did not alter pain-independent behaviors, whereas negative controls would not. Consistent with this prediction, ketoprofen (0.1-32 mg/kg) produced the expected analgesic profile, whereas oxycodone (0.32-3.2 mg/kg) alleviated all IP acid effects except depression of rearing at doses lower than those that altered pain-independent behaviors. For the negative controls, diazepam (1-10 mg/kg) failed to block IP acid-induced depression of either rearing or nesting and only decreased IP acid-stimulated behaviors at doses that also decreased pain-independent behaviors. Amphetamine (0.32-3.2 mg/kg) alleviated all IP acid effects but only at doses that also stimulated locomotion. These results support utility of this model as a framework to evaluate candidate-analgesic effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behavioral endpoints. SIGNIFICANCE STATEMENT: Preclinical assays of pain and analgesia often yield false-positive effects with candidate analgesics. This study used two positive-control analgesics (ketoprofen, oxycodone) and two active negative controls (diazepam, amphetamine) to validate a strategy for distinguishing analgesics from nonanalgesics by profiling drug effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behaviors in male and female mice.
本研究评估了一系列疼痛刺激、疼痛抑制和与疼痛无关的行为,以对候选镇痛药物在小鼠中的临床前药理学进行评估。腹腔内注射稀释的乳酸(IP 酸)作为急性内脏疼痛刺激物,可在雄性和雌性 ICR 小鼠中产生四种与疼痛相关的行为:1)伸展刺激,2)面部痛苦表情,3)抬举抑制,4)筑巢抑制。此外,在没有疼痛刺激的情况下进行筑巢和运动,以评估与疼痛无关的药物作用。这六种行为用于比较两种机制上不同但临床上有效的阳性对照物(酮洛芬和羟考酮)和两种不是临床上批准的镇痛药但产生要么是一般性运动抑制(地西泮)要么是运动刺激(安非他命)的阴性对照物的作用。我们预测,在不改变与疼痛无关的行为的情况下,镇痛药会缓解所有 IP 酸的作用,而阴性对照物则不会。与这一预测一致,酮洛芬(0.1-32mg/kg)产生了预期的镇痛作用,而羟考酮(0.32-3.2mg/kg)缓解了除了抑制抬举之外的所有 IP 酸作用,其剂量低于改变与疼痛无关的行为的剂量。对于阴性对照物,地西泮(1-10mg/kg)未能阻止 IP 酸诱导的抬举或筑巢抑制,仅在降低 IP 酸刺激行为的剂量下降低 IP 酸刺激的行为。安非他命(0.32-3.2mg/kg)缓解了所有 IP 酸的作用,但仅在刺激运动的剂量下。这些结果支持将该模型作为一种框架,用于在一系列互补的疼痛刺激、疼痛抑制和与疼痛无关的行为终点中评估候选镇痛药物的效果。
疼痛和镇痛的临床前检测经常会导致候选镇痛药产生假阳性效应。本研究使用两种阳性对照镇痛药(酮洛芬、羟考酮)和两种活性阴性对照物(地西泮、安非他命),通过在雄性和雌性小鼠中一系列互补的疼痛刺激、疼痛抑制和与疼痛无关的行为中对药物作用进行分析,来区分镇痛药和非镇痛药,验证了一种策略的有效性。